Contact
searchSearch
HMP Global

Conference Coverage

Conference Coverage
Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI
12/27/2023
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management
12/26/2023
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Gregory McDermott, MD: Predictors of RA-ILD and Subtypes
12/26/2023
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Breakthrough COVID-19 Infection Among RA Patients After Third Dose
12/26/2023
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients
12/20/2023
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Rheumatoid Arthritis and Long COVID—A Double Whammy
12/20/2023
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Is There a Window of Opportunity in Psoriatic Arthritis?
12/13/2023
Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.
Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.
Early referral to...
12/13/2023
Rheumatology & Arthritis
Conference Coverage
Vibeke Strand, MD, on Results of the Phase 3 SELECT-EARLY Trial
12/12/2023
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial...
12/12/2023
Rheumatology & Arthritis
Conference Coverage
JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study
12/05/2023
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been...
12/05/2023
Rheumatology & Arthritis
Conference Coverage
PsA and PsO Affecting Work Productivity?
11/20/2023
Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.
Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.
Dr Nancy Shadick explains the...
11/20/2023
Rheumatology & Arthritis

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Popular Articles

News
Composite Measures in Rheumatology May Hamper Personalized Care
02/18/2021
Composite indices to assess for rheumatic and musculoskeletal diseases are valuable in clinical trials, but in clinical practice, they may not accurately reflect the real complexity of these diseases.
Composite indices to assess for rheumatic and musculoskeletal diseases are valuable in clinical trials, but in clinical practice, they may not accurately reflect the real complexity of these diseases.
Composite indices to assess for...
02/18/2021
Rheumatology & Arthritis
Poll: Multidisciplinary Approach to PsA
Poll
Poll: Multidisciplinary Approach to PsA
12/14/2020
A multidisciplinary approach to psoriatic arthritis (PsA) management can help in the optimization of a treatment plan. When managing PsA, are you typically satisfied with the level of communication you have...
A multidisciplinary approach to psoriatic arthritis (PsA) management can help in the optimization of a treatment plan. When managing PsA, are you typically satisfied with the level of communication you have...
...
12/14/2020
Rheumatology & Arthritis
EULAR Publishes Definition for Difficult-to-Treat RA
EULAR Publishes Definition for Difficult-to-Treat RA
10/15/2020
The European League Against Rheumatism (EULAR) has proposed a definition for difficult-to-treat rheumatoid arthritis (RA). According to the task force that developed the definition, uniform terminology and an...
The European League Against Rheumatism (EULAR) has proposed a definition for difficult-to-treat rheumatoid arthritis (RA). According to the task force that developed the definition, uniform terminology and an...
The...
10/15/2020
Rheumatology & Arthritis
NMES Improves Strength After Knee Replacement Surgery
NMES Improves Strength After Knee Replacement Surgery
07/08/2020
Patients who use neuromuscular electrical stimulation (NMES) following total knee arthroplasty (TKA) experience statistically significant gains in quadriceps strength compared with patients who do not receive NMES, a...
Patients who use neuromuscular electrical stimulation (NMES) following total knee arthroplasty (TKA) experience statistically significant gains in quadriceps strength compared with patients who do not receive NMES, a...
Patients...
07/08/2020
Rheumatology & Arthritis
Clifford Rosen, MD, on the Endocrine Society`s Latest Osteoporosis Guideline
Clifford Rosen, MD, on the Endocrine Society`s Latest Osteoporosis Guideline
04/28/2020
04/28/2020
Rheumatology & Arthritis

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use